Debrisoquin hydroiodide

Category	SARS-CoV
CAS	1052540-65-4
Description	Debrisoquin is an adrenergic neuron-blocking drug similar in effects to guanethidine. It is an antihypertensive drug with antioxidant, anti-inflammatory, and neuroprotective properties. It can regulate the activity of certain neurotransmitters, including dopamine and serotonin, which makes it a promising candidate for treating neurological disorders, such as Parkinson's disease and depression.

Quotation Now

Synonyms	Debrisoquin hydriodide;1052540-65-4;1,2,3,4-tetrahydroisoquinoline-2-carboximidamide hydroiodide;DEBRISOQUIN HYDROIODIDE;Debrisoquin (hydroiodide);3,4-Dihydro-1H-isoquinoline-2-carboxamidine hydriodide;3,4-dihydro-1H-isoquinoline-2-carboximidamide;hydroiodide;Debrisoquin HI;MFCD07681953;AKOS008030907;HY-W195509;TS-09054;CS-0258218;EN300-69426;Z118438370;3,4-dihydroisoquinoline-2(1H)-carboximidamide hydroiodide;
IUPAC Name	3,4-dihydro-1H-isoquinoline-2-carboximidamide;hydroiodide
Molecular Weight	303.14
Molecular Formula	C10H14IN3
Canonical SMILES	N=C(N1CC2=C(CC1)C=CC=C2)N.I
InChI	InChI=1S/C10H13N3.HI/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13;/h1-4H,5-7H2,(H3,11,12);1H
InChIKey	FSDNBVFWOCFLIE-UHFFFAOYSA-N
Purity	≥95%
Solubility	Soluble in DMSO
Appearance	Solid
Storage	4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)